Company intelligence / Profile preview

Younger America

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Younger America is a health technology company specializing in longevity and biological age assessment. The company offers advanced diagnostic testing, including epigenetic clocks, to measure an individual's biological age relative to their chronological age. Based on these insights, Younger America provides personalized health and wellness recommendations aimed at slowing the aging process and improving healthspan. Their platform integrates data from various biomarkers to offer a comprehensive view of an individual's aging profile and track the effectiveness of longevity interventions.

Therapeutic areas: Other
Modalities: DiagnosticsPersonalized Medicine
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Younger America.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Younger America.

Explore the full profile